Cargando…

Antifungal Activity and Mode of Action of Miltefosine Against Clinical Isolates of Candida krusei

Candida krusei attracts attention from medical professionals mainly for its intrinsic resistance to fluconazole and the limited number of drugs available to treat C. krusei vulvovaginal candidiasis. Miltefosine was demonstrated to have good antifungal activity both in vitro and in vivo. Here, we det...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yongqin, Wu, Mengying, Gao, Jing, Ying, Chunmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248313/ https://www.ncbi.nlm.nih.gov/pubmed/32508766 http://dx.doi.org/10.3389/fmicb.2020.00854

Ejemplares similares

Clinical Characteristics of Turkish Women with Candida krusei Vaginitis and Antifungal Susceptibility of the C. krusei Isolates
por: Güzel, Ahmet Bariş, et al.
Publicado: (2013)

Promising antifungal activity of new oxadiazole against Candida krusei
por: Faria, Daniella Renata, et al.
Publicado: (2020)

Multilocus Sequence Typing and Antifungal Susceptibility of Vaginal and Non-vaginal Candida glabrata Isolates From China
por: Chen, Yisheng, et al.
Publicado: (2022)

Genetic Differentiation, Diversity, and Drug Susceptibility of Candida krusei
por: Gong, Jie, et al.
Publicado: (2018)

Mechanism of Antifungal Activity by 5-Aminoimidazole-4-Carbohydrazonamide Derivatives against Candida albicans and Candida krusei
por: Cerqueira, Fátima, et al.
Publicado: (2021)

Understanding the Antifungal Mechanism of Ag@ZnO Core-shell Nanocomposites against Candida krusei
por: Das, Bhaskar, et al.
Publicado: (2016)

Cardiac Candida krusei infection
por: Wiwanitkit, Viroj
Publicado: (2010)

S2.4d Combination antifungal effects of eugenol with voriconazole against Candida tropicalis and Candida krusei strains isolated from the genital tract of mares
por: Sharifzadeh, Aghil, et al.
Publicado: (2022)

Molecular Phylogenetic Analysis of Candida krusei
por: Domán, Marianna, et al.
Publicado: (2022)

Miltefosine Against Scedosporium and Lomentospora Species: Antifungal Activity and Its Effects on Fungal Cells
por: Rollin-Pinheiro, Rodrigo, et al.
Publicado: (2021)

Antifungal Resistance Profile, Biofilm Formation, and Virulence Factor Production in Candida krusei Isolates From HIV-Infected Patients in Cameroon
por: Kountchou, Cyrille Levis, et al.
Publicado: (2023)

A Trypsin Inhibitor from Tecoma stans Leaves Inhibits Growth and Promotes ATP Depletion and Lipid Peroxidation in Candida albicans and Candida krusei
por: Patriota, Leydianne L. S., et al.
Publicado: (2016)

Whole Genome Sequence of the Heterozygous Clinical Isolate Candida krusei 81-B-5
por: Cuomo, Christina A., et al.
Publicado: (2017)

Upregulation of the ERG11 gene in Candida krusei by azoles
por: Tavakoli, M., et al.
Publicado: (2010)

Renal allograft pyelonephritis and fungemia due to Candida krusei
por: Westervelt, Justin D., et al.
Publicado: (2014)

Case report: Candida krusei spondylitis in an immunocompromised patient
por: Overgaauw, Audrey J. C., et al.
Publicado: (2020)

Synergistic and antagonistic effects of immunomodulatory drugs on the action of antifungals against Candida glabrata and Saccharomyces cerevisiae
por: Tome, Miha, et al.
Publicado: (2018)

Antifungal Efficacy during Candida krusei Infection in Non-Conventional Models Correlates with the Yeast In Vitro Susceptibility Profile
por: Scorzoni, Liliana, et al.
Publicado: (2013)

Antifungal susceptibility profiles and drug resistance mechanisms of clinical Candida duobushaemulonii isolates from China
por: Chen, Xin-Fei, et al.
Publicado: (2022)

Nanocarriers Provide Sustained Antifungal Activity for Amphotericin B and Miltefosine in the Topical Treatment of Murine Vaginal Candidiasis
por: de Bastiani, Fernanda Walt Mendes da Silva, et al.
Publicado: (2020)

Alkylimidazolium Ionic Liquids as Antifungal Alternatives: Antibiofilm Activity Against Candida albicans and Underlying Mechanism of Action
por: Reddy, G. Kiran Kumar, et al.
Publicado: (2020)

Recombinant polymerase amplification combined with lateral flow strips for the detection of deep-seated Candida krusei infections
por: Zhao, Mengdi, et al.
Publicado: (2022)

A cluster of Candida krusei infections in a haematological unit
por: Hautala, Timo, et al.
Publicado: (2007)

Risk Factors and Mortality Associated with Candida krusei Bloodstream Infections
por: Kronen, Ryan, et al.
Publicado: (2017)

Biosorption Performance of Encapsulated Candida krusei for the removal of Copper(II)
por: Luk, Chi Him Jim, et al.
Publicado: (2017)

P357 Update on risk factors for Candida krusei-Fungemia
por: Jansen, Julia C., et al.
Publicado: (2022)

Morphological characteristics of Candida albicans, Candida krusei, Candida guilliermondii, and Candida glabrata biofilms, and response to farnesol
por: Sachivkina, Nadezhda, et al.
Publicado: (2021)

Mechanism of Antifungal Action of Monoterpene Isoespintanol against Clinical Isolates of Candida tropicalis
por: Contreras Martínez, Orfa Inés, et al.
Publicado: (2022)

Blood Stream Infections by Candida glabrata and Candida krusei: A Single-Center Experience
por: Choi, Hee Kyoung, et al.
Publicado: (2009)

Photodynamic Antifungal Activity of Hypocrellin A Against Candida albicans
por: Yang, Yijia, et al.
Publicado: (2019)

Microsatellite Typing and Antifungal Susceptibility of Candida glabrata Strains Isolated From Patients With Candida Vaginitis
por: Kiasat, Neda, et al.
Publicado: (2019)

Differential recognition of Candida tropicalis, Candida guilliermondii, Candida krusei, and Candida auris by human innate immune cells
por: Navarro-Arias, María J, et al.
Publicado: (2019)

A Novel Dual-Targeted α-Helical Peptide With Potent Antifungal Activity Against Fluconazole-Resistant Candida albicans Clinical Isolates
por: Yang, Yang, et al.
Publicado: (2020)

Overexpression of Both ERG11 and ABC2 Genes Might Be Responsible for Itraconazole Resistance in Clinical Isolates of Candida krusei
por: He, Xiaoyuan, et al.
Publicado: (2015)

Anti-candidal activity of a novel peptide derived from human chromogranin A and its mechanism of action against Candida krusei
por: LI, RUI-FANG, et al.
Publicado: (2015)

Antifungal Activity and Mechanism of Action of the Co(III) Coordination Complexes With Diamine Chelate Ligands Against Reference and Clinical Strains of Candida spp.
por: Turecka, Katarzyna, et al.
Publicado: (2018)

Screening of Chemical Libraries for New Antifungal Drugs against Aspergillus fumigatus Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine
por: dos Reis, Thaila Fernanda, et al.
Publicado: (2021)

Antifungal Activity of Minocycline and Azoles Against Fluconazole-Resistant Candida Species
por: Tan, Jingwen, et al.
Publicado: (2021)

Liquid crystal precursor mucoadhesive system as a strategy to improve the prophylactic action of Syngonanthus nitens (Bong.) Ruhland against infection by Candida krusei
por: dos Santos Ramos, Matheus Aparecido, et al.
Publicado: (2015)

Strong Synergism of Palmatine and Fluconazole/Itraconazole Against Planktonic and Biofilm Cells of Candida Species and Efflux-Associated Antifungal Mechanism
por: Wang, Tianming, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_viq0nofb9e5pmv6olf3mbu35v8